Amgen
The latest news about Amgen: headlines, AI summaries and the full story from every source.
- Amgen Reports Positive Late-Stage Trial Results for Experimental Drug Targeting Sjögren’s Disease
- Morgan Stanley Highlights Amgen's Competitive Position After Novartis Heart Drug Trial Failure
- Amgen Stock Drops Sharply Amid Novartis' Lp(a)-Lowering Drug Failure
- Positive Lung Cancer Trial Results for Amgen's Imdelltra and AstraZeneca's Imfinzi
- Dow Jones Falls Sharply Due to Novartis' Failed Drug Trials
- Stocks Slide Amid Rising Oil Prices and Geopolitical Tensions
- U.K. Regulator Suspends Use of Amgen's Avacopan Due to Data Concerns
- Schwab U.S. Dividend Equity ETF (SCHD) Sees $679M Inflows Amid Strong Performance
- Amgen Faces Regulatory Challenges but Dividend Appears Secure
- CFO Changes at Amgen, Thales, and Rent the Runway
- Amgen Rehires Former CFO Thomas Dittrich with $12.5M Compensation Package
- Amgen's Tavneos Linked to 20 Deaths in Japan
- Pfizer and Amgen Among 22 Firms Expanding in Hong Kong